Cite
APA Citation
Perez-Garcia, G., Bicak, M., Haure-Mirande, J., Perez, G. M., Otero-Pagan, A., Gama Sosa, M. A., De Gasperi, R., Sano, M., Barlow, C., Gage, F. H., Readhead, B., Ehrlich, M. E., Gandy, S., & Elder, G. A. (2023). bCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPTP301S mouse model of tauopathy. Neuroscience letters, 797, . http://access.bl.uk/ark:/81055/vdc_100179396393.0x00003f